Novo Nordisk expects Wegovy approval in China this year: report

admin

Novo Nordisk expects Wegovy approval in China this year: report


Ole Schwander

Novo Nordisk (NVO) reportedly expects its popular weight-loss drug Wegovy to be approved in China this year, but plans to launch the product in the massive Asian market with capped volumes.

Speaking at an investors meeting in Copenhagen, Christine Zhou Xiaping, headaccording to Reuters

SOURCE

MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MLB MLB MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL MBL

Leave a Comment

MlL MlL MlL MlL MlL MlL MlL MlL MlL MlL MlL MlL MlL MlL MlL MlL MlL MlL MlL MlL MlL MlL MlL MlL MlL MlL MlL MlL MlL MlL